Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-01 Sale |
2023-11-03 7:38 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
10,000 | $28.75 | $287,500 | 156,786 (Direct) |
View |
| 2023-10-17 Sale |
2023-10-19 5:01 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Krasner Alan Seth Chief Medical Officer |
7,000 | $30 | $210,000 | 196,683 (Direct) |
View |
| 2023-07-11 Sale |
2023-07-13 4:56 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
50,000 | $20.21 | $1,010,317 | 1,027,327 (Indirect Direct) |
View |
| 2023-06-20 Sale |
2023-06-21 5:32 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
30,922 | $19.97 | $617,403 | 166,343 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-21 5:27 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
50,000 | $20.81 | $1,040,500 | 1,077,327 (Indirect Direct) |
View |
| 2023-06-08 Purchase |
2023-06-09 08:00 am |
Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director |
5,000 | $22.06 | $110,300 | 5,000 (Direct) |
View |
| 2023-04-05 Sale |
2023-04-05 7:12 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Development Officer |
8,212 | $16.15 | $132,624 | 4,500 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 4:30 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,126 | $19.59 | $61,238 | 64,689 (Direct) |
View |
| 2023-01-25 Sale |
2023-01-27 4:26 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
8,336 | $21.07 | $175,640 | 67,815 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 4:28 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,126 | $18 | $56,268 | 76,151 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 4:23 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,126 | $18.35 | $57,362 | 79,277 (Direct) |
View |
| 2022-12-15 Sale |
2022-12-19 5:11 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,126 | $16 | $50,016 | 82,403 (Direct) |
View |
| 2022-12-01 Sale |
2022-12-05 5:28 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,126 | $17.84 | $55,768 | 84,968 (Direct) |
View |
| 2022-11-15 Sale |
2022-11-17 4:46 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,126 | $18.72 | $58,519 | 88,094 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 4:35 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,126 | $18.52 | $57,894 | 91,220 (Direct) |
View |
| 2022-10-17 Sale |
2022-10-19 5:34 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,126 | $17.73 | $55,424 | 94,346 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-11-01 Exercise |
2023-11-03 7:38 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
10,000 | $9.28 | 156,786 (Direct) |
View |
| 2023-11-01 Exercise |
2023-11-03 7:38 pm |
N/A 2028-05-24 |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
10,000 | $0 | 156,786 (Direct) |
View |
| 2023-10-17 Exercise |
2023-10-19 5:01 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Krasner Alan Seth Chief Medical Officer |
7,000 | $12.01 | 196,683 (Direct) |
View |
| 2023-10-17 Exercise |
2023-10-19 5:01 pm |
N/A 2028-06-15 |
Crinetics Pharmaceuticals Inc. | CRNX | Krasner Alan Seth Chief Medical Officer |
7,000 | $0 | 196,683 (Direct) |
View |
| 2023-08-14 Exercise |
2023-08-16 4:30 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
10,000 | $1.91 | 1,188,597 (Direct) |
View |
| 2023-08-14 Exercise |
2023-08-16 4:30 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
10,000 | $0 | 1,188,597 (Direct) |
View |
| 2023-06-20 Exercise |
2023-06-21 5:32 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
20,000 | $9.28 | 166,343 (Direct) |
View |
| 2023-06-20 Exercise |
2023-06-21 5:32 pm |
N/A 2028-05-24 |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
20,000 | $0 | 166,343 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director |
23,500 | $0 | 28,500 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Crinetics Pharmaceuticals Inc. | CRNX | WIERENGA WENDALL Director |
23,500 | $0 | 123,346 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Crinetics Pharmaceuticals Inc. | CRNX | Okey Stephanie Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
23,500 | $0 | 36,036 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2023-04-03 Tax Withholding |
2023-04-05 7:12 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Development Officer |
4,288 | $15.98 | 4,500 (Direct) |
View |
| 2023-03-16 Tax Withholding |
2023-03-17 5:11 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
1,666 | $17.12 | 106,080 (Direct) |
View |
| 2023-03-16 Tax Withholding |
2023-03-17 5:10 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
4,628 | $17.12 | 1,127,327 (Direct) |
View |
| 2023-03-16 Tax Withholding |
2023-03-17 5:09 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Krasner Alan Seth Chief Medical Officer |
1,687 | $17.12 | 42,301 (Direct) |
View |
| 2023-03-16 Tax Withholding |
2023-03-17 5:08 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
587 | $17.12 | 34,400 (Direct) |
View |
| 2023-03-16 Tax Withholding |
2023-03-17 5:07 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
1,410 | $17.12 | 86,879 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:47 pm |
N/A 2033-02-28 |
Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer |
79,250 | $0 | 79,250 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:44 pm |
N/A 2033-02-28 |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Development Officer |
25,500 | $0 | 38,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:43 pm |
N/A 2033-02-28 |
Crinetics Pharmaceuticals Inc. | CRNX | Krasner Alan Seth Chief Medical Officer |
110,500 | $0 | 134,988 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:38 pm |
N/A 2033-02-28 |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
133,600 | $0 | 198,289 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:35 pm |
N/A 2033-02-28 |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
120,500 | $0 | 125,987 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:33 pm |
N/A 2033-02-28 |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
137,050 | $0 | 220,596 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:31 pm |
N/A 2033-02-28 |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
349,350 | $0 | 1,419,655 (Direct) |
View |
| 2022-05-20 Ownership |
2023-01-27 4:29 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
1,928 | $11.02 | 85,474 (Direct) |
View |
| 2022-05-20 Ownership |
2023-01-27 4:28 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Krasner Alan Seth Chief Medical Officer |
1,927 | $11.02 | 26,415 (Direct) |
View |
| 2022-11-20 Ownership |
2023-01-27 4:27 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
537 | $15.16 | 6,024 (Direct) |
View |
| 2022-10-12 Exercise |
2022-10-14 4:55 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
11,100 | $1.91 | 1,231,575 (Direct) |
View |
| 2022-10-12 Exercise |
2022-10-14 4:55 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
11,100 | $0 | 1,231,575 (Direct) |
View |